XTLB
XTL Biopharmaceuticals
XTLB
XTLB
5 hedge funds and large institutions have $907K invested in XTL Biopharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$67K |
| 2 |
2
Morgan Stanley
New York
|
$2K |
Top Sellers
| 1 |
SM
1
Sabby Management
Miami Beach,
Florida
|
$714K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $714K | 150,258 | -49,976 | -25% |
|
2
Invesco
Atlanta,
Georgia
| $123K | 25,962 | – | – |
|
|
3
Citadel Advisors
Miami,
Florida
| $67K | 14,118 | +14,118 | New |
|
|
4
Morgan Stanley
New York
| $2K | 520 | +400 | +333% |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $1K | 120 | – | – |
|